Merganser Biotech
Get Full AccessDescription
- Merganser Biotech is a clinical-stage biotechnology company developing a novel drug class for hematological diseases. Mergansers lead compound, M012, is currently under evaluation in a Phase 1 clinical program as a potentially transformative therapy for a number of diseases including beta thalassemia, low risk myelodysplasia (MDS), polycythemia vera (PV), alpha thalassemia, and sickle cell disease.
-
Headquarters:1004 W 9Th Ave Ste 115, King Of Prussia, Pennsylvania, United States
More -
Phone Number: +1 484-681-4214
-
-
Employees:0
-
Revenue:
-
Legal Name:Merganser Biotech
-
Merganser Biotech's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Merganser Biotech
-
Where are Merganser Biotech's Headquarters?
Merganser Biotech's Headquarters are in 1004 W 9Th Ave Ste 115,King Of Prussia,Pennsylvania,United States
-
What is Merganser Biotech's phone number?
Merganser Biotech's phone number is +1 484-681-4214
-
What is Merganser Biotech's NAICS code?
Merganser Biotech's NAICS code is 541713
-
What is Merganser Biotech's Industry?
Merganser Biotech is in the industry of Biotechnology
-
Who is Merganser Biotech's Head Of Global Clinical Research And Development?
Merganser Biotech's Head Of Global Clinical Research And Development is Mark Falone